Global MarketsAugust 3 at 01:06 PM

Fresenius Medical (FME GY) Revenue EUR 4.86bln (exp. 4.78bln); confirms FY26 outlook

StockNow breaking-news AI analysis

Fresenius Medical reported a revenue beat of EUR 4.86bn for Q2 2026 and confirmed its full-year outlook, supported by ongoing FME25+ efficiency gains despite persistent cost pressures.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLY Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

U.S. Economy